Literature DB >> 12391841

[Polymorphisms of the candidate genes for genetic susceptibility to tuberculosis in the Slavic population of Siberia: a pilot study].

V P Puzyrev1, M B Freĭdin, A A Rudko, A K Strelis, O V Kolokolova.   

Abstract

The 469 + 14 G/C (INT4), 1465 - 85 G/A, and C274T polymorphisms of NRAMP1 and the A/C polymorphism of IL12 3'-UTR were analyzed in ethnic Russians with (N = 58) or without (N = 127) tuberculosis (TB) from Tomsk. On evidence of allele and genotype frequencies, none of the polymorphisms was associated with TB. In the healthy controls, the three NRAMP1 polymorphisms were in linkage disequilibrium with each other (P < 0.001) but not with the IL12 polymorphism. Still the four polymorphisms are potentially informative as concerns their association with TB.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391841

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  4 in total

1.  Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study.

Authors:  Marlo Möller; Almut Nebel; Paul D van Helden; Stefan Schreiber; Eileen G Hoal
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

Review 2.  Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?

Authors:  William R Berrington; Thomas R Hawn
Journal:  Immunol Rev       Date:  2007-10       Impact factor: 12.988

Review 3.  SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis.

Authors:  XiangWei Li; Yu Yang; Feng Zhou; Yunzhi Zhang; Hongzhou Lu; Qi Jin; Lei Gao
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

4.  Sex- and age-dependent association of SLC11A1 polymorphisms with tuberculosis in Chinese: a case control study.

Authors:  Kim Hung Leung; Shea Ping Yip; Wa Sang Wong; Lap San Yiu; Kam Keung Chan; Wai Man Lai; Eudora Y D Chow; Che Kit Lin; Wing Cheong Yam; Kin Sang Chan
Journal:  BMC Infect Dis       Date:  2007-03-19       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.